Skip to main content

Table 1 Clinical characteristics of 30 AGC patients

From: Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA

Clinical characteristics

Case (n)

Percentage

Gender

 Male

20

66.7

 Female

10

33.3

Age

 Median

64.0

 

 Range

37–77

 

Tumor site

 Fundus

6

20.0

 Body

10

33.3

 Antrum

14

46.7

Hematogenous metastasis

 Yes

17

56.7

 No

13

43.3

Regimens

  

 Pt-3d

14

46.7

  FLOT

11

–

  DOS

3

–

 Pt-2d

16

53.3

  SOX

12

–

  CAPOX

3

–

  FOLFOX

1

–

 PTX

5

16.7

  Paclitaxel

2

–

  PX

2

–

  Nab-paclitaxel

1

–

 CPT-11

6

20.0

  IRIR

4

–

  Irinotecan

1

–

  FOLFIRI

1

–

Treatment pattern

 Pt-3d to CPT-11

6

20.0

 Pt-2d to PTX

5

16.7

ORR of 1st-line

 PR

15

50.0

 SD

10

33.3

 PD

5

16.7

  1. AGC advanced gastric cancer